Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (17)

2023

  1. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435

2022

  1. CD69 expression on regulatory T cells protects from immune damage after myocardial infarction

    The Journal of clinical investigation, Vol. 132, Núm. 21

2021

  1. Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review

    Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 245-257

2020

  1. Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis †

    Cells, Vol. 9, Núm. 9

  2. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

  3. The evolving microbiome from pregnancy to early infancy: A comprehensive review

    Nutrients, Vol. 12, Núm. 1

2019

  1. CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions

    Scientific Reports, Vol. 9, Núm. 1

  2. Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1

    FASEB Journal, Vol. 33, Núm. 3, pp. 3912-3921

  3. Rationale and Study Design for an Individualized Perioperative Open Lung Ventilatory Strategy in Patients on One-Lung Ventilation (iPROVE-OLV)

    Journal of Cardiothoracic and Vascular Anesthesia, Vol. 33, Núm. 9, pp. 2492-2502

2018

  1. MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis

    Nature Communications, Vol. 9, Núm. 1

2017

  1. Rationale and study design for an individualised perioperative open-lung ventilatory strategy with a high versus conventional inspiratory oxygen fraction (iPROVE-O2) and its effects on surgical site infection: Study protocol for a randomised controlled trial

    BMJ Open, Vol. 7, Núm. 7

  2. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

  2. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792

  3. Rationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): Study protocol for a randomized controlled trial

    Trials, Vol. 16, Núm. 1

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

1996

  1. Informe sobre resistencia microbiana: ¿qué hacer?

    Medicina Clinica